ScholarIQanswers from OpenAlex

Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress

PaperCitations, authors & open-access status

Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress have?

ScholarIQcitation count

Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress has 113 citations in the OpenAlex counts ScholarIQ stores.

When was Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress published?

ScholarIQyear

Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress has 2022 year in the ScholarIQ index.

What is the open-access status of Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress?

ScholarIQoa status

Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress has green oa status in the ScholarIQ index.

What is the DOI of Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress?

ScholarIQdoi

The DOI for Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress is on the source record.

What is the PMID of Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress?

ScholarIQpmid

The PMID for Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress is on the source record.

What is the OpenAlex record for Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress?

ScholarIQopenalex

The OpenAlex for Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial